Axsome Therapeutics Joins the Global Narcolepsy Community in Raising Awareness on World Narcolepsy Day

NEW YORK, Sept. 21, 2023 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a biopharmaceutical company developing and delivering novel therapies for the management of central nervous system (CNS) disorders, today announced it is joining the global narcolepsy advocacy community, including more than 20 global patient advocacy organizations across six continents, to raise awareness of the impact that narcolepsy has on World Narcolepsy Day, Sept. 22, 2023.

In support of World Narcolepsy Day, Axsome is sponsoring several awareness events:

• On Sept. 21 at 6 p.m. Eastern Time, Axsome is sponsoring a virtual panel where an international group of experts will discuss narcolepsy around the world, organized by Wake Up Narcolepsy. Registration and details for the panel event can be found here.
• On Sept. 29-Oct. 1, Axsome is a sponsor of and is attending “Thrive Together,” Narcolepsy Network’s 37th Annual Conference, a multi-day event to learn, engage, and connect with people with narcolepsy and their supporters, being held in Denver, Colo. More details about the conference can be found here.

Axsome is committed to developing innovative therapies that make an impact on the lives of people suffering from CNS disorders, including those with narcolepsy and other sleep disorders. As part of that mission, Axsome’s works closely with advocacy and other patient groups to support their efforts to provide a network and resources for patients and their families and to raise awareness of these conditions globally.

Narcolepsy is a serious and debilitating neurological condition that affects one out of 2000 people including an estimated 185,000 people in the U.S. alone. It has been shown to occur in people of any race and most commonly shows up in people aged 15-30. Narcolepsy has been shown to interfere with thinking and emotional and social functioning and is associated with increased risk of work- or driving-related accidents including a 1.5x higher mortality rate. These statistics highlight the significant public health burden that narcolepsy represents, as well as a need for improvements in access to treatments.

For more information about narcolepsy, World Narcolepsy Day, as well as additional resources for patients, please learn more about the following organizations and their affiliates:

• Wake Up Narcolepsy (https://www.wakeupnarcolepsy.org/): a nonprofit organization dedicated to driving narcolepsy awareness, education and research towards improved treatments and a cure.
• Narcolepsy Network (https://narcolepsynetwork.org/): is a national patient support organization dedicated to education, support and assistance, advocacy, and resources for people with narcolepsy.
• Sleep Research Society (https://sleepresearchsociety.org/): an organization for scientific investigators who educate and research sleep and circadian science.
• Sleep Consortium (https://sleepconsortium.org/): a non-profit organization created to accelerate next generation research, disease understanding, and therapy development for those living with Central Disorders of Hypersomnolence (CDoH) and related diseases.
• National Sleep Foundation (https://www.thensf.org/): an independent nonprofit, dedicated to improving overall health and well-being by advancing sleep health.